<DOC>
	<DOCNO>NCT02365922</DOCNO>
	<brief_summary>Frontotemporal Lobar Degeneration ( FTLD ) neuropathological term collection rare neurodegenerative disease correspond four main overlap clinical syndrome : frontotemporal dementia ( FTD ) , primary progressive aphasia ( PPA ) , corticobasal degeneration syndrome ( CBS ) progressive supranuclear palsy syndrome ( PSPS ) . The goal study build FTLD clinical research consortium support development FTLD therapies new clinical trial . The consortium , refer Advancing Research Treatment Frontotemporal Lobar Degeneration ( ARTFL ) , headquarter UCSF partner six patient advocacy group manage consortium . Participants evaluate 14 clinical site throughout North America genetics core genotype individual FTLD associate gene .</brief_summary>
	<brief_title>Advancing Research Treatment Frontotemporal Lobar Degeneration ( ARTFL )</brief_title>
	<detailed_description>Frontotemporal Lobar Degeneration ( FTLD ) neuropathological term collection rare neurodegenerative disease correspond four main overlap clinical syndrome : frontotemporal dementia ( FTD ) , primary progressive aphasia ( PPA ) , corticobasal degeneration syndrome ( CBS ) progressive supranuclear palsy syndrome ( PSPS ) . The goal study build FTLD clinical research consortium ( FTLD CRC ) support development FTLD therapies new clinical trial . The FTLD CRC headquarter UCSF partner six patient advocacy group manage consortium . Patients evaluate 13 clinical site throughout North America genetics core genotype individual FTLD associate gene . The study divide 2 project . The first project Preparing Sporadic FTLD Clinical Trials second project Longitudinal Assessment Familial FTLD . Self-registration online registry available patient family FTLD syndrome . Eligible participant research Projects 1 2 FTLD invite CRC site clinical evaluation . All enrol participant research project site visit consist neurological exam , medical family history , cognitive testing , blood draw . Participants Project 1 diagnosis Progressive Supranuclear Palsy Syndrome two additional assessment . A lumbar puncture ( LP ) perform CSF collection , MRI scan brain do . Participants Project 2 : Longitudinal Assessment familial FTLD return follow-up visit 12 month ; procedures follow-up visit identical baseline . Additionally , asymptomatic participant undergo MRI scan visit .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Aphasia</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Frontotemporal Lobar Degeneration</mesh_term>
	<mesh_term>Primary Progressive Nonfluent Aphasia</mesh_term>
	<criteria>1 . Must meet one follow research diagnostic criterion Frontotemporal lobar degeneration ( FTLD ) syndrome : behavioral variant frontotemporal dementia ( bvFTD ) , primary progressive aphasia ( PPA ) , semantic variant primary progressive aphasia ( svPPA ) , nonfluent variant primary progressive aphasia ( nfvPPA ) , frontotemporal dementia amyotrophic lateral sclerosis ( FTD/ALS ) , amyotrophic lateral sclerosis alone , corticobasal syndrome ( CBS ) , progressive supranuclear palsy ( PSP ) oligosymptomatic PSP ( oPSP ) , strong family history FTLD syndromes . 2 . Between 18 85 ( inclusive ) year age . 3 . Able walk ( assistance ) time enrollment . 4 . Have reliable study partner provide independent evaluation functioning . 5 . Speak English Spanish 6 . Have Mini Mental State Exam ( MMSE ) score 15 30 ( inclusive ) . 1 . Known presence structural brain lesion ( e.g . tumor , cortical infarct ) could reasonably explain symptom symptomatic participant without know fFTLD cause mutation . 2 . Known presence Alzheimer 's disease cause mutation PSEN1 , PSEN2 APP ; neuropathological evidence Alzheimer 's disease cause syndrome ( brain biopsy ) . 3 . A previous history Korsakoff encephalopathy , severe alcohol dependence ( within 5 year onset dementia ) , frequent alcohol substance intoxication , neurological disorder ( multiple sclerosis ) 4 . Evidence history laboratory test B12 deficiency ( B12 &lt; 95 % local laboratory 's normal value ) , hypothyroidism ( TSH &gt; 150 % normal ) , HIV positive , renal failure ( creatinine &gt; 2 ) , liver failure ( ALT AST &gt; two time normal ) , respiratory failure ( require oxygen ) , extraaxial brain tumor ( visible compression brain parenchyma ) , large cerebral infarct could account clinical syndrome , large confluent white matter lesion ( grade 3 4 , [ 107 ] significant systemic medical illness deteriorate cardiovascular disease ; 5 . Current medication likely affect CNS function opinion site PI : long act benzodiazepine diazepam ( shortacting benzodiazepine OK ) , nonSSRI antidepressant ( SSRIs trazodone OK ) , lithium , typical neuroleptic list Manual Procedures , narcotic ( codeine OK , hold 24 hour neuropsychological test ) , anticonvulsant ( outside therapeutic range ) , antihistamine ( take great three time per week ; hold 24 hour neuropsychological test ) . 6 . In site investigator 's opinion , participant complete sufficient key study procedure , equivalent assessment impairment level . 7 . For group MRI scan plan procedure , contraindication MRI scanning , pacemaker implanted metal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>FTLD , PSP , CBD , PPA , FTD , FTD-ALS , CBS , ALS , svPPA , nfvPPA , oPSP</keyword>
</DOC>